March 17, 2023 - March 21, 2023

Dev Labtech Venture IPO Review & Recommendations

Dilip Davda has given "May Apply" recommendation to Dev Labtech Venture IPO.

Dev Labtech Venture IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	1	0	0	0
%	0.00	100.00	0.00	0.00	0.00

Dev Labtech Venture IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	May Apply

Dev Labtech Venture IPO Review by Dilip Davda (May apply)

[Dilip Davda] DLVL which was in natural diamond manufacturing and marketing has recently diversified in lab-grown diamonds with MPCVD technology. It has marked growth in its PAT margins post-diversification and the management is confident of maintaining the trends in coming years with the addition of more MPCVD machines. Based on FY23 earnings, the issue appears aggressively priced. Well-informed/cash-surplus/risk seekers may consider parking funds, while others can ignore. Read detail review...

Dev Labtech Venture IPO Review by Members

Dev Labtech Venture IPO Reviews, analysis and views by popular members. Read Dev Labtech Venture Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Dev Labtech Venture IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	1	0	0	5
%	16.67	0.00	0.00	83.33

Member	Review
ForeverLearner	Avoid The Price to Earnings is 60 as per the DRHP based on the FY 2022 earnings and I consider this too high a valuation with no listed peers to justify the valuation, also the remuneration drawn by the directors cumulatively is Rs 7/lacs per annum which is totally unjustified. March 21, 2023 12:53:29 PM
CA Sunil	Avoid Poor financial aggressively price. Surely not long term stock. Short term depends upon operators. For me clear avoid. March 18, 2023 3:05:33 PM
Anil sme	Avoid diamond busines March 17, 2023 2:58:33 PM
IPO LEADER IPO Mentor (800+ Posts, 400+ Likes)	Avoid High valuation March 17, 2023 9:22:17 AM
St	Apply for Long Term at Upper Price Band I'm apply hni March 16, 2023 9:57:30 PM
RajaBanks	Avoid > Valuation is questionable > Company recently started the lab diamonds growth business, prior to this they were just trading diamonds.( It takes a small room to grow Diamonds, Maybe the Ingrown diamonds are just the decoy for the IPO) > Cut Throat competition in the diamond market. > Poor EPS despite being a trading company too Nutshell- Avoid. Money saved is Money Earned. March 14, 2023 3:35:49 PM

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.